15250-m-cuypers

21 General introduction 1 15. van StamM-A, van der Poel HG, van der Voort van Zyp JRN, Tillier CN, Horenblas S, Aaronson NK, et al. The accuracy of patients’perceptions of the risks associated with localised prostate cancer treatments. BJU International.n/a-n/a. 16. Zeliadt SB, Ramsey SD, Penson DF, Hall IJ, Ekwueme DU, Stroud L, et al. Why do men choose one treatment over another? Cancer. 2006;106(9):1865-74. 17. Huggins C, Scott WW, Heinen JH. CHEMICAL COMPOSITION OF HUMAN SEMEN AND OF THE SECRETIONS OF THE PROSTATE AND SEMINAL VESICLES. American Journal of Physiology -- Legacy Content. 1942;136(3):467-73. 18. Leissner KH, Tisell LE. The Weight of the Human Prostate. Scandinavian Journal of Urology and Nephrology. 1979;13(2):137-42. 19. Kanker.nl. Prostaatkanker (Prostate cancer) [Available from: https://www.kanker.nl/ bibliotheek/prostaatkanker/wat-is/72-prostaatkanker. 20. SobinLH, Fleming ID.TNMclassificationofmalignant tumors, (1997). Cancer. 1997;80(9):1803- 4. 21. Garisto JD, Klotz L. Active Surveillance for Prostate Cancer: How to Do It Right. Oncology (Williston Park, NY). 2017;31(5). 22. Rao AR, Motiwala HG, Karim OMA. The discovery of prostate-specific antigen. BJU International. 2008;101(1):5-10. 23. Loeb S, Bjurlin MA, Nicholson J, Tammela TL, Penson DF, Carter HB, et al. Overdiagnosis and Overtreatment of Prostate Cancer. European Urology. 2014;65(6):1046-55. 24. RIVM. Volksgezondheid Toekomst Verkenning 2014 [Available from: http://www. nationaalkompas.nl . 25. Stangelberger A, Waldert M, Djavan B. Prostate Cancer in Elderly Men. Reviews in Urology. 2008;10(2):111-9. 26. Jahn JL, Giovannucci EL, Stampfer MJ. The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate- specific Antigen-era. International Journal of Cancer. 2015;137(12):2795-802. 27. Bellardita L. Patient's choice of observational strategy for earlystage prostate cancer. Neuropsychol Trends. 2012;12:107-16. 28. Punnen S, Cowan JE, Chan JM, Carroll PR, Cooperberg MR. Long-term Health-related Quality of Life After Primary Treatment for Localized Prostate Cancer: Results from the CaPSURE Registry. European Urology. 2015;68(4):600-8. 29. Huang GJ, Sadetsky N, Penson DF. Health Related Quality of Life for MenTreated for Localized Prostate Cancer With Long-Term Followup. The Journal of Urology. 2010;183(6):2206-12. 30. Namiki S, Arai Y. Health-related quality of life in men with localized prostate cancer. International Journal of Urology. 2010;17(2):125-38. 31. Penson DF, Litwin MS, Aaronson NK. Health Related Quality of Life in Men With Prostate Cancer. The Journal of Urology. 2003;169(5):1653-61. 32. Cooperberg MR, Carroll PR, Klotz L. Active Surveillance for Prostate Cancer: Progress and Promise. Journal of Clinical Oncology. 2011;29(27):3669-76.